Asia Pacific Fill Finish Manufacturing Market Forecast to 2030 - Regional Analysis - by Product, Modality, and End User

The Asia Pacific fill finish manufacturing market was valued at US$ 1.86 billion in 2022 and is expected to reach US$ 4.20 billion by 2030; it is estimated to grow at a CAGR of 10.7% from 2022 to 2030.

Low Business Costs in Emerging Markets Boosts Asia Pacific Fill Finish Manufacturing Market

Many Asian countries are emerging as attractive outsourcing locations for various biopharmaceutical manufacturers across the globe. Low manufacturing and operating costs in China, India, and other countries in Asia are the key factors boosting contract manufacturing. Moreover, recent developments in the biopharmaceutical industry in China and India indicate significant potential for the market. The growing pipelines of biologics and biosimilars are further opening new avenues for the contract manufacturers in APAC. Contract manufacturing mostly benefits early-stage drug innovators owing to lower operational costs. To meet the growing demand, many CMOs are expanding their manufacturing capabilities. For instance, in January 2020, STA Pharmaceutical Co., Ltd - a WuXi AppTec company - opened a new large-scale oligonucleotide active pharmaceutical ingredient (API) manufacturing facility in China.

Asia Pacific Fill Finish Manufacturing Market Overview

In Asia Pacific, China is the largest market for fill finish manufacturing. The growth of the market is primarily attributed to the rising technological advancements in fill finish manufacturing processes in China, increasing developments by the market players, the biopharmaceutical industry’s expansion, and the growing prevalence of chronic diseases. There are more than 500 biological product/biopharmaceutical companies in China. Most of those involved in R&D were established by returnees from abroad or by Western/joint venture companies. Although estimates vary widely, analysts believe that the Chinese government spends more than US$ 600 million annually on biotech R&D through its funding initiatives. China’s national and local governments also invest in quasi-venture capital companies that invest in IT enterprises.

The market players are expanding their business through organic and inorganic growth strategies. For instance, WuXi Biologics increased the capacity of prefilled syringes (PFS) to 17 million units yearly in June 2022 by opening its drug product factory in Wuxi, China.

The most recent D.P. facility operated by WuXi Bio, a contract development manufacturing organization (CDMO), is called DP5, and it has an advanced isolator filling line for reliable, continuous filling services. According to the company, this provides PFS with a variety of volume delivery options, including 1.25 mL, 3 mL, 1 mL, and 1 mL.

Asia Pacific Fill Finish Manufacturing Market Revenue and Forecast to 2030 (US$ Million)

Asia Pacific Fill Finish Manufacturing Market Segmentation

The Asia Pacific fill finish manufacturing market is segmented based on product, modality, end user, and country. Based on product, the Asia Pacific fill finish manufacturing market is bifurcated into consumables and instruments. The consumables segment held a larger market share in 2022. Furthermore, the consumables is sub segmented into prefilled syringes, glass vial/plastic vials, cartridges, and others.

In terms of modality, the Asia Pacific fill finish manufacturing market is segmented into recombinant proteins, monoclonal antibodies, vaccines, cell therapies and biological therapies, gene therapies, and others. The vaccines segment held the largest market share in 2022.

By end user, the Asia Pacific fill finish manufacturing market is categorized into contract manufacturing organizations, biopharmaceutical companies, and others. The contract manufacturing organizations segment held the largest market share in 2022.

Based on country, the Asia Pacific fill finish manufacturing market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China dominated the Asia Pacific fill finish manufacturing market share in 2022.

Becton Dickinson and Co, Gerresheimer AG, IMA Industria Macchine Automatiche SpA, Maquinaria Industrial Dara SL, Nipro Medical Asia Pacific NV, NNE AS, Optima Packaging Group Gmbh, Schott AG, SGD SA, Stevanato Group SpA, Syntegon Technology GmbH, and West Pharmaceutical Services Inc are some of the leading players operating in the Asia Pacific fill finish manufacturing market.

Reasons to Buy:

• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific fill finish manufacturing market.
• Highlights key business priorities in order to assist companies to realign their business strategies.
• The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific fill finish manufacturing market, thereby allowing players across the value chain to develop effective long-term strategies.
• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
• Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the Asia Pacific fill finish manufacturing market, as well as those hindering it.
• Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.